S&T Bank’s Novartis NVS Stock Holding History

S&T Bank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-180	Closed	-$21.8K	–	516
2025 Q2	$21.8K	Hold	180	–	–	0.01%	195
2025 Q1	$20.1K	Buy	+180	New	+$19.2K	0.01%	192

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

S&T Bank's NVS Position: Q3 2025 in Review

S&T Bank sold out of Novartis (NVS) in Q3 2025, closing a stake of 180 shares — an estimated $21.8K sold.

S&T Bank first reported a position in NVS in Q1 2025 and held it in 2 quarters. The position peaked at $21.8K in Q2 2025. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

S&T Bank reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
S&T Bank sold 180 Novartis shares in Q3 2025, an estimated $21.8K.
S&T Bank first reported a position in Novartis in Q1 2025 and held it in 2 quarters.
S&T Bank's Novartis position peaked at $21.8K in Q2 2025.
1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on S&T Bank's 13F filing for Q3 2025, filed 14 Nov 2025.